BRIEF-Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone

* Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.